Advertisement

Interferon and Interleukin-2 Therapy of Kaposi’s Sarcoma

  • P. A. Volberding
  • C. B. Wofsy
  • D. I. Abrams
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 187)

Abstract

It is difficult to treat Kaposi’s sarcoma by conventional therapies in the setting of immune deficiency such as the acquired immunodeficiency syndrome (AIDS), because this treatment may cause further immune suppression. In AIDS, cytotoxic chemotherapy may, for example, increase the risk of opportunistic infections such as Pneumocystis pneumonia. Thus, this therapy, even if successful against the tumor, may potentially shorten survival. Because of these factors, experimental therapy with immune modulating agents has been particularly attractive in AIDS-related Kaposi’s sarcoma. The two agents receiving most attention have been recombinant alpha interferon and recombinant interleukin–2. These will be the subject of this review. The results will be preliminary because the disease itself is so new and because many of the clinical trials of these agents are still in progress.

Keywords

Opportunistic Infection Acquire Immunodeficiency Syndrome Pneumocystis Pneumonia Immune Modulate Agent Adverse Immunological Consequence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    B. Safai, R. A. Good, Kaposi’s sarcoma: A review in recent developments. Clin Bulletin 10: 62–69 (1980).Google Scholar
  2. 2.
    P. H. O’Brien and R. D. Brasfield, Kaposi’s sarcoma. Cancer 19: 1497–1502 (1966).PubMedCrossRefGoogle Scholar
  3. 3.
    K. B. Hymes, T. Cheung, J. B. Green, Kaposi’s sarcoma in homosexual men. Report of 8 cases, Lancet i i: 598–600 (Sept. 1981).Google Scholar
  4. 4.
    R. Kriegel, L. Laubenstein, F. Muggia, Kaposi’s sarcoma: A new staging classification. Cancer Treatment Reports 67: 531–534 (1983).Google Scholar
  5. 5.
    P. Volberding, K. Kaslo, M. Bilk, Prognostic factors in staging Kaposi’s sarcoma in. the acquired immunodeficiency syndrome. Proceedings American Society of Clinical Oncology, p 19, (1984).Google Scholar
  6. 6.
    P. Volberding, M. A. Conant, R. B. Strieker, B. J. Lewis, Chemotherapy in advanced Kaposi’s sarcoma: Implications for current cases in homosexual men. Am J Med 74: 652–656 (1983).PubMedCrossRefGoogle Scholar
  7. 7.
    J. H. Siegel, R. Janis, J. Alper, et al, Disseminated Kaposi’s sarcoma - appearance after human renal aligraft operation. JAMA 207: 1493–1496 (1969).PubMedCrossRefGoogle Scholar
  8. 8.
    B. D. Myers, E. Kessler, J. Levi, et al, Kaposi’s sarcoma in kidney transplant patients. Arch Int Med 133: 307–311 (1974).CrossRefGoogle Scholar
  9. 9.
    S. E. Krown, F. X. Real, S. Cunningham-Rundles, et al, Preliminary observations on the effect of recombinant leukocyte interferon in homosexual men with Kaposi’s sarcoma. New Engl J Med 308: 1071–1076 (1983).PubMedCrossRefGoogle Scholar
  10. 10.
    J. E. Groopman, M. S. Gottlieb, J. Goodman, et al, Recombinant alpha–2 interferon therapy of Kaposi’s sarcoma associated with acquired immunodeficiency syndrome. Ann Int Med 100: 671–677 (1984).PubMedGoogle Scholar
  11. 11.
    K. Welte, N. Ciobanun, G. Kruger, Impaired interleukin–2 production in response to PHA and OKT3 antibody in male homosexuals with acquired immunodeficiency syndrome: in vitro restoration of T-cell proliferation by highly purified interleukin–2, in: “AIDS, The Epidemic of Kaposi’s Sarcoma and Opportunistic Infections,” A. E. Friedman-Kien, L. J. Laubenstein, Masson Publishing U.S.A. Inc., New York, 199–205, (1983).Google Scholar
  12. 12.
    A. H. Rook, H. Masur, H. C. Lane, et al, Interleukin–2 enhances the depressed natural killer in cytomegalovirus specific cytotoxic activities of lymphocytes from patients with the acquired immunodeficiency syndrome. J Clin Invest 72: 398–403 (1983).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • P. A. Volberding
    • 1
  • C. B. Wofsy
    • 1
  • D. I. Abrams
    • 1
  1. 1.AIDS ClinicSan Francisco General HospitalSan FranciscoUSA

Personalised recommendations